Inactive Instrument
Legion Metals Corp Stock Canadian Securities Exchange
Stocks
CA52490L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.8M 4.91M 4.21M 3.94M 3.6M 469M 6.86M 46.43M 18.07M 236M 18.44M 18.04M 782M | P/E 2024 |
-8x | P/E 2025 | -71.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.81M 4.92M 4.21M 3.94M 3.6M 469M 6.87M 46.49M 18.09M 237M 18.46M 18.07M 783M | EV / Sales 2024 |
1.05x | EV / Sales 2025 | 1.05x |
| Free-Float |
98.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -71.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 2023-09-07 |
Ted Kim
DFI | Director of Finance/CFO | - | - |
Sam Kassem
DFI | Director of Finance/CFO | - | 2023-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Andrews
BRD | Director/Board Member | - | 2023-09-26 |
Sherry Boodram
BRD | Director/Board Member | - | 2019-10-15 |
Fred Bonner
BRD | Director/Board Member | 64 | 2024-02-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -71.43% | -.--% | - | - | 4.91M | ||
| +0.89% | +4.46% | +15.98% | +15.98% | 2.57B | ||
| +1.62% | +19.54% | +41.85% | +220.68% | 2.15B | ||
| -1.79% | -2.38% | -50.20% | +252.14% | 532M | ||
| 0.00% | +3.64% | -9.52% | +42.50% | 62.96M | ||
| Average | -14.14% | +5.59% | -0.47% | +132.83% | 1.33B | |
| Weighted average by Cap. | +0.84% | +8.79% | +19.50% | +122.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.48M 9.01M 7.73M 7.23M 6.61M 861M 12.59M 85.23M 33.17M 434M 33.86M 33.12M 1.44B | 11.26M 8.14M 6.97M 6.52M 5.97M 777M 11.37M 76.94M 29.94M 392M 30.56M 29.9M 1.3B |
| Net income | -1.44M -1.04M -889K -832K -761K -99.06M -1.45M -9.81M -3.82M -49.94M -3.9M -3.81M -165M | -163K -118K -101K -94.38K -86.31K -11.24M -164K -1.11M -433K -5.67M -442K -433K -18.75M |
| Net Debt | -53.84K -38.9K -33.34K -31.19K -28.52K -3.71M -54.33K -368K -143K -1.87M -146K -143K -6.2M | 7.72K 5.58K 4.78K 4.47K 4.09K 533K 7.79K 52.76K 20.53K 269K 20.96K 20.5K 889K |
Employees
-
Sector
Pharmaceuticals
















